Iterum Therapeutics plc Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Iterum Therapeutics plc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Iterum Therapeutics plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 20M shares, a 53.7% increase year-over-year.
  • Iterum Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 13M shares, a 5.93% increase from 2022.
  • Iterum Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 12.2M shares, a 12.4% increase from 2021.
  • Iterum Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 10.9M shares, a 580% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 20M +7M +53.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 16.6M +3.61M +27.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 15.4M +2.75M +21.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 13M +726K +5.93% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 13M +806K +6.59% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 12.9M +719K +5.88% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 12.7M +488K +4.01% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 12.2M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 12.2M +51.4K +0.42% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 12.2M -168M -93.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 12.2M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 12.2M -8.21M -40.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 180M +164M +1053% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q3 2020 20.4M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 15.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.